InvestorsHub Logo
icon url

BooDog

12/20/18 5:09 PM

#252291 RE: snayeman #252290

We're setting up the blocks to begin P3 or Brilacidin-OM. News on Monday was promising.
The big ticket is who's going to pay for it. We're stuck till that comes out.

Imo

icon url

williamssc

12/20/18 5:11 PM

#252292 RE: snayeman #252290

What more needs to be said. I mean anything and everything has already been said. It's approaching the eleventh hour, It's up to Leo now. A deal after EOP2 meeting has been all but spelled out in fire works show. Go Leo, light the fuse.
icon url

Cognition

12/20/18 10:10 PM

#252331 RE: snayeman #252290

“One of the holy grails of medicine is to come up with a stable, simple and easy to synthesize organic molecule, one that could be taken orally as a pill, and would function like a protein itself. This truly is one of the great holy grails of pharmaceutical research. The technology that Bill DeGrado and Mick Klein have developed achieves exactly this, using a variety of computational algorithms to mathematically design compounds which mimic the activity of proteins themselves. These compounds can be polymers, which are larger compounds that can be used as materials, and oligomers and small molecules, which can be used as drugs. Thus, biomimetics”.

Hopefully people will recognize the history. When and How it was created. What type of genius minds we’re using computer algorithms to engineer new types of drugs.
B is a pipeline. Anyone can see for themselves if they actually took the time to look.
Partnership for phase 3 for B for OM will be first. IBD will remain in house for now. Multi partnership future is IPIX’s plan for B. Taking their time because they know what they own. They know the history and who created it. They know partnership is coming imo. And so is a pill for K soon! P53 modulation achieved!
2nd Partnership will be for K. AJMO
Happy Everything everybody! Enjoy